
Sign up to save your podcasts
Or


For malignant brain cancers, such as glioblastoma, treatment options have not significantly improved. The current standard of care involves surgery followed by radiation or chemotherapy.
Dr. Kesari and his team are exploring a new approach. The PNI (Precision Immunotherapy in the Neoadjuvant setting) method uses targeted treatments based on the patient's tumor genetics before administering chemotherapy and radiation, when the immune system is stronger.
The goal is to prime the body to recognize and target the cancer as a foreign entity, enabling the body's own immune system to combat the disease before it is weakened by chemotherapy and radiation.
Learn more: 310-829-8265
By Think Neuro5
1818 ratings
For malignant brain cancers, such as glioblastoma, treatment options have not significantly improved. The current standard of care involves surgery followed by radiation or chemotherapy.
Dr. Kesari and his team are exploring a new approach. The PNI (Precision Immunotherapy in the Neoadjuvant setting) method uses targeted treatments based on the patient's tumor genetics before administering chemotherapy and radiation, when the immune system is stronger.
The goal is to prime the body to recognize and target the cancer as a foreign entity, enabling the body's own immune system to combat the disease before it is weakened by chemotherapy and radiation.
Learn more: 310-829-8265

43,713 Listeners

14,366 Listeners

500 Listeners

656 Listeners

112,942 Listeners

24,342 Listeners

27 Listeners

9,200 Listeners

145 Listeners

1,104 Listeners

6,397 Listeners

29,248 Listeners

16,098 Listeners

20,208 Listeners

24 Listeners